Rodolphe Thiébaut, Edouard Lhomme, Hakim Hocini, Isabelle Pellegrin, Andrea Boizard-Moracchini, Alexandre Duvignaud, Maud Perpère, Mélanie Huchon, Mélanie Prague, Christine Lacabaratz, Mathieu Surenaud, Xavier Anglaret, Denis Malvy, Boris P. Hejblum, Yves Levy, COVERAGE study group.. Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19. 2026. iScience. 29. 2114593.
Ange-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, Abdoul Beavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh, Samba Sow, Linda Wittkop , Anne-Aygline Soutthiphong, Irina Maljkovic Berry, Suzanne Fleck, Pauline Akoo , Benjamin Hamze, Deborah Watson-Jones, Jens H Kuhn , Brian Greenwood, Laura Richert, Yazdan Yazdanpanah, Yves Lévy, Rodolphe Thiébaut, Mélanie Prague; PREVAC Study Team; Edouard Lhomme. . Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.. 2026. PLOS Neglected Tropical Diseases. 20. e0013950.
Pierre Jais, Petr Neuzil, Daniel Scherr, Eric Frison, Sebastien Knecht, Serge Boveda , Isabel Deisenhofer, Philippe Maury, Thomas Deneke, Hubert Cochet, Marine Rousset,Valentine Renaudeau, Elena Sauer, Maxime Sermesant, Josef Kautzner, Nico Erhard, Dan Wichterle. Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial. 2026. European Heart Journal. ehaf1115. .
Lehané Masebo, Tim Whitfield, Harriet Demnitz-King, Amanda Heslegrave, Géraldine Poisnel, Antoine Lutz, Eric Frison, Miranka Wirth, Abdul Hye, Frank Jessen, Nicholas J Ashton, Henrik Zetterberg, Natalie L Marchant. Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial. 2025. The Journal of Prevention of Alzheimer's Disease. 12. 100299.
Lacabaratz C, Durand M, Wiedemann A, Foucat E, Surénaud M, Krief C, Guillaumat L, Robinson C, Luhn K, Bockstal V, Thiébaut R, Richert L, Lévy Y. Innate and cellular immune response to the Ebola vaccine Ad26.ZEBOV, MVA-BN-Filo: an ancillary study of the EBL2001 phase II trial. 2025. The Journal of Infectious Diseases. 231. 230-240.
Valayer, Simon; Alexandre, Marie; Prague, Mélanie; Beavogui, Abdoul Habib; Doumbia, Seydou; Kieh, Mark; Greenwood, BrianORCID logo; Leigh, Bailah; Poupelin, Marie; Schwimmer, Christine; Sow, Samba O; Berry, Irina Maljkovic; Kuhn, Jens H; Fusco, Daniela; Cauwelaert, Natasha Dubois; Watson-Jones, Deborah; Thiébaut, Rodolphe; Lévy, Yves; Yazdanpanah, Yazdan; Richert, Laura; Lhomme, Edouard; and PREVAC study team (2025). Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial. 2025. Emerging Microbes & Infections. 14. 0.
Luke Paterson, Rachel A Elliott, Fofi Constantinidou, Renaud David, Piers Dawes, Eric Frison, Mark Hann, Hannah Hussain, Iracema Leroi, Antonis M Politis, Chryssoula Thodi, Elizabeth M Camacho ; SENSE‐Cog Study Team. The Cost-Effectiveness of an Intervention to Preserve Independence in People With Dementia (Vs. No Intervention): A Decision-Analytic (Markov) Model Analysis. 2025. International Journal of Geriatric Psychiatry. 40. e70132.
Alexopoulos P, Demertzis AA, Biris P, Economou P, Frison E, Dawes P, Leroi I. Pragmatic questionnaire-based evaluation of auditory function in individuals with major neurocognitive disorders and hearing loss in diverse contexts. 2025. Frontiers in Aging Neuroscience. 17. 1504358.
Iracema Leroi, Christopher J Armitage, Elizabeth M Camacho, Anna Pavlina Charalambous, J P Connelly, Fofi Constantinidou, Renaud David, Piers Dawes, Rachel A Elliott, Mark Hann, Alison Holden, Emma Hooper, Sean P Kennelly, Evangelia Kontogianni, Brian A Lawlor, Julie Longobardi, Luke Paterson, Antonis M Politis, David Reeves, Christine Schwimmer, Chryssoula Thodi, Mark Worthington, Wai Kent Yeung, Eric Frison ; SENSE-Cog Study Team. Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trial. 2024. The Lancet Healthy Longevity. 5. 100625.
